Avalo Therapeutics (AVTX) Gross Profit (2017 - 2024)
Avalo Therapeutics posted quarterly Gross Profit of -$465000.0 for Q3 2024, down 4127.27% year-on-year from $11546.3 in Q4 2023, and down 35.57% on a QoQ basis from -$343000.0 in Q2 2024.
Avalo Therapeutics (AVTX) has 8 years of Gross Profit data on file, last reported at -$465000.0 in Q3 2024.
- For the quarter ending Q3 2024, Gross Profit fell 4127.27% year-over-year to -$465000.0; the trailing twelve-month figure through Sep 2024 stood at -$96000.0 (down 177.42% YoY), and the FY2023 full-year result was $640000.0, down 95.62% from the prior year.
- Gross Profit for Q3 2024 stood at -$465000.0, down from -$343000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $14.4 million in Q3 2022 and bottomed at -$623000.0 in Q4 2020.
- The 5-year median for Gross Profit is $276000.0 (2022), against an average of $1.1 million.
- The widest annual swing landed in 2022, when Gross Profit surged 3162.67%; it then slumped 4127.27% in 2024.
- A 5-year view of Gross Profit shows it stood at -$623000.0 in 2020, then surged by 67.09% to -$205000.0 in 2021, then jumped by 234.63% to $276000.0 in 2022, then surged by 186.96% to $792000.0 in 2023, then slumped by 158.71% to -$465000.0 in 2024.
- The last three Gross Profit figures came in at -$465000.0 (Q3 2024), -$343000.0 (Q2 2024), and -$80000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -465,000.00 |
| Sep 30, 2024 | -465,000.00 |
| Jun 30, 2024 | -343,000.00 |
| Jun 30, 2024 | -343,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 14.42 Mn |
| Sep 30, 2022 | 14.42 Mn |
| Jun 30, 2022 | -534,000.00 |
| Jun 30, 2022 | -534,000.00 |
| Mar 31, 2022 | 453,000.00 |
| Mar 31, 2022 | 453,000.00 |
| Dec 31, 2021 | -205,000.00 |
| Dec 31, 2021 | -205,000.00 |
| Sep 30, 2021 | 442,000.00 |
| Sep 30, 2021 | 442,000.00 |
| Jun 30, 2021 | 3.27 Mn |
| Jun 30, 2021 | 3.27 Mn |
| Mar 31, 2021 | 396,000.00 |
| Mar 31, 2021 | 396,000.00 |
| Dec 31, 2020 | -623,000.00 |
| Dec 31, 2020 | -623,000.00 |
| Sep 30, 2020 | 1.03 Mn |
| Sep 30, 2020 | 1.03 Mn |
| Jun 30, 2020 | 685,000.00 |
| Jun 30, 2020 | 685,000.00 |
| Mar 31, 2020 | 2.08 Mn |
| Mar 31, 2020 | 2.08 Mn |
| Dec 31, 2019 | 33,107.00 |
| Dec 31, 2019 | 33,107.00 |
| Sep 30, 2019 | 2.07 Mn |
| Sep 30, 2019 | 2.07 Mn |
| Jun 30, 2019 | -104,735.00 |
| Jun 30, 2019 | -104,735.00 |
| Mar 31, 2019 | 2.18 Mn |
| Mar 31, 2019 | 2.18 Mn |
| Dec 31, 2018 | -1.46 Mn |
| Dec 31, 2018 | -1.46 Mn |
| Sep 30, 2018 | 963,496.00 |
| Sep 30, 2018 | 963,496.00 |
| Jun 30, 2018 | 2.74 Mn |
| Jun 30, 2018 | 2.74 Mn |
| Mar 31, 2018 | 4.47 Mn |
| Mar 31, 2018 | 4.47 Mn |
| Dec 31, 2017 | 1.28 Mn |
| Dec 31, 2017 | 1.28 Mn |
| Sep 30, 2017 | 25.04 Mn |
| Sep 30, 2017 | 25.04 Mn |
| Jun 30, 2017 | 157,800.00 |
| Jun 30, 2017 | 157,800.00 |
| Mar 31, 2017 | 384,206.00 |
| Mar 31, 2017 | 384,206.00 |